MaRS Innovation - MI
| Focus: |
To put Canada on the global innovation stage, by better connecting research with industry and strengthening Canada's competitive capacity in knowledge-based businesses - in short, to launch a new generation of robust, high-growth Canadian companies that will become global market leaders. |
| Funding: |
$29,911,150 for entire funding period |
| Centre Director: |
Dr. Raphael Hofstein |
| Web site: |
 www.marsinnovation.com |
News
2013
May 15
Five UTEST companies to tackle critical healthcare challenges
May 8
Dr. Raphael Hofstein in Biotechnology Focus: Building a catalytic reaction across Canada’s Life Sciences Sector
May 7
Financial Post profiles OtoSim Inc.’s innovative medical learning device
May 7
Canadian biotech sector makes strong showing at BIO2013
April 29
How Canada’s health-care industry is riding a wave of transition
April 24
Flybits recognized as a context-aware tool for marketing professionals
April 23
ClevrU Corp. acquires NewMindsets Inc. to transform online education market
April 22
Merck invests in pan-Canadian life sciences research innovation sector
April 22
MaRS Innovation announces new strategic partnership with Pfizer
April 18
Minuum’s crowdfunding campaign raises 873 per cent of initial goal
April 17
Stem Cell Therapeutics licenses UHN’s Clinical Cancer Stem Cell Program
April 9
BioDiaspora Founder: Travellers unlikely to bring H7N9 bird flu to Canada
March 26
What does MaRS Innovation’s funding extension mean for Toronto’s academic entrepreneurs?
March 25
Minuum closes on $60,000 crowdfunded stretch goal to build wearable development kit
March 18
Minuum to end battle between mobile screen space and virtual keyboards
March 7
ScarX Therapeutics featured on cover of Bioworld Today
February 27
OtoSim Night revolutionizes how students learn to identify ear pathologies
February 25
Flybits founder Dr. Hossein Rahnama appointed to NSERC Council
February 21
Flybits to exhibit at Mobile World Congress 2013, officially launch Flybits LITE
February 19
FedDev Ontario awards Xagenic Inc. $990,000 through Investing in Business Innovation initiative
February 19
XLV Diagnostics Inc. awarded $500,000 to develop digital mammography technology
February 6
MaRS Innovation awarded $15 million to further commercialize world-leading Canadian innovations
February 4
DLVR: Using personalized medicine and nature’s cellular toolkit to target cancer tumours
January 24
OCE invests $250,000 in ScarX Therapeutics’ revolutionary anti-scarring medication
January 23
Globe and Mail and Global News Toronto cover early-stage Bio Printer technology
January 18
Xconomy names Xagenic to 2012′s Biotech Startup Class
2012
December 11
Bedside Clinical Systems featured in Philadelphia’s MedCity News
December 6
Kaypok selects Zync to power its global "big data" technology brand
December 4
Kaypok Unveils Root Cause Analysis Solution for Why Consumers Behave
November 27
VitalHub's Chart Makes Apple’s Top 80 List of Doctor Apps
November 26
MI Inventors Poon and Rahnama Pitch EMTech 2012 (Videos Online)
November 23
OtoSim featured in Health Research & Innovation, receives B Corp Designation (video)
November 19
Gen Magazine features Dr. Aaron Wheeler's research in microfluidics
November 13
Dr. Raphael Hofstein's guest column posted on Biotechnology Focus
November 13
OICR and MaRS Innovation announce funding to develop Cellax™, a nanotechnology-based cancer drug
November 8
Stem Cell Therapeutics, UHN and MaRS Innovation Announce Novel, Clinical-Stage, Cancer Stem Cell Program Agreement
November 7
Yonge Street Media covers Bedside Clinical Systems' launch
October 29
Bedside Clinical Systems aims to bring better healthcare to children
October 23
Shotlst CEO featured in Globe article on future of tech in education
October 4
Partnership to invest up to $1M in promising Canadian healthcare discoveries
October 2
ClevrU partners with Schulich School of Business Professors to target online education market
October 1
U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies
September 18
CML HealthCare Inc. and MaRS Innovation Enter into Strategic Partnership
September 18
VP Joel Liederman's Financial Post article on mitigating innovation risk
September 18
BioCentury features Encycle Therapeutics and MaRS Innovation in macrocycle chemistry article
August 27
Hossein Rahnama, CEO of Flybits, on CBC's Lang & O'Leary Exchange
August 24
Two MI inventors named to MIT’s 35 inventors under 35 list
August 20
Huffington Post Canada interviews Raphael Hofstein about Canadian venture capital shortage
August 13
VP Joel Liederman: MaRS Innovation, Canadian Research and the Commercialization Test
July 24
BioCentury Features Xagenic’s PCR-Based Infection-Diagnosis Technology
July 11
Attend an Information Session in Toronto or Montreal to Learn About New Funding for Biomedical Research Technologies
July 11
Los Angeles Times covers Dr. Gregory Czarnota’s cancer therapy technology
July 3
Business Without Borders features Encycle Therapeutics, Raphael Hofstein
June 28
Raphael Hofstein's editorial in National Post’s Medical Devices supplement
June 18
Encycle Therapeutics Launches Ground-Breaking Chemistry Platform
June 18
CQDM Partners with MaRS Innovation, Ontario Brain Institute and Ontario Centres of Excellence to Launch Life Sciences Funding Program Within Ontario-Québec Corridor
June 2
OtoSim Inc. Makes a Sound Pitch on BNN
May 22
Flybits CEO Presents Mobile Technology Platform to the Prince of Wales
2010
March 2
CIHR Commercialization Program funds insulin-alternative stem cell technology and nicotine addiction drug therapy
2009
June 30
MaRS Innovation selects diabetic wound healing technology from The University of Toronto as its second commercialization opportunity
June 29
MaRS Innovation selects umbilical cord stem cell technology from Samuel Lunenfeld Research Institute of Mount Sinai Hospital as its first commercialization opportunity
June 1
MaRS Innovation Appoints President and CEO
Show more +
